newsfilter
← Latest News
GlobeNewswire·

Vigil Neuroscience Appoints Christopher J. Silber, M.D. as Chief Medical Officer

WATERTOWN, Mass., Aug. 07, 2023 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative